Table 1 Patients and tumours characteristics (n = 53)
Smoking | 48 (90.6) |
Family history of lung cancer | 15 (28.3) |
Personal history of cancer | 3 (5.7) |
Comorbidities | 17 (32.1) |
Presentation | |
Incidental finding | 10 (18.9) |
Solitary pulmonary nodule | 1 (1.9) |
Cough | 50 (40.3) |
Dyspnoea | 18 (34.0) |
Pain | 13 (24.5) |
Haemoptysis | 12 (22.6) |
Constitutional syndrome | 27 (50.9) |
Histology | |
Adenocarcinoma | 28 (52.8) |
Epidermoid | 16 (30.2) |
Undifferentiated | 5 (9.4) |
Large cell | 3 (5.7) |
Neuroendocrine | 1 (1.9) |
Treatment | |
CCT with platinum | 46 (86.8) |
CCT and RT | 7 (13.2) |
Stage | |
IIB | 3 (5.7) |
IIIA | 7 (13.2) |
IIIB | 11 (20.8) |
IV | 32 (60.4) |
RECIST-1.1 diameter (mm) | 59 ± 22 (21–115) |
Volume (cc) | 107 ± 137 (1–605) |
Time from baseline PCT to CCT start (days) 29.37 ± 15.8 (8–82) | |
Time from CCT start to control PCT (days) 63.9 ± 28.1 (42–138) | |